Related Experiment Video
Updated: Dec 12, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
MicroRNA-125b reduces glucose uptake in papillary thyroid carcinoma cells
Guowu Zhang1, Sihai Zhou1, Quan Yang2
1Department of General Surgery, Yongchuan Hospital of Chongqing Medical University, Chongqing 402160, P.R. China.
Abstract:
Previous studies have shown that microRNA (miR)-125b plays important roles in several human cancer types. The aim of the present study was to analyze the potential roles of miR-125b in papillary thyroid carcinoma (PTC). It was found that miR-125b was downregulated in PTC and its expression was affected by clinical stages. Glucose transporter 1 (GLUT1) was upregulated in PTC and was negatively correlated with miR-125b. In PTC cells, overexpression of miR-125b suppressed glucose uptake and downregulated GLUT1. Furthermore, GLUT1 overexpression reduced the effects of miR-125b overexpression on glucose uptake. Moreover, miR-125b overexpression suppressed PTC cell proliferation. GLUT1 overexpression promoted the proliferation of PTC cells and reduced the effects of miR-125b overexpression on cancer cell proliferation. Overall, miR-125b decreased glucose uptake in PTC cells by downregulating GLUT1.
Insights
MicroRNA (miR)-125b is downregulated in papillary thyroid carcinoma (PTC), impacting cancer progression. This study reveals miR-125b suppresses PTC cell proliferation and glucose uptake by targeting glucose transporter 1 (GLUT1).
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- MicroRNA (miR)-125b is implicated in various human cancers.
- Its specific role in papillary thyroid carcinoma (PTC) requires further elucidation.
Purpose of the Study:
- To investigate the function of miR-125b in papillary thyroid carcinoma (PTC).
- To explore the relationship between miR-125b, glucose transporter 1 (GLUT1), and PTC progression.
Main Methods:
- Analysis of miR-125b and GLUT1 expression in PTC tissues.
- In vitro studies involving overexpression of miR-125b and GLUT1 in PTC cells.
- Assessment of glucose uptake and cell proliferation rates.
Main Results:
- miR-125b was found to be downregulated in PTC, with expression levels varying by clinical stage.
- GLUT1 was upregulated in PTC and showed a negative correlation with miR-125b expression.
- Overexpression of miR-125b in PTC cells led to suppressed glucose uptake and reduced GLUT1 levels.
- miR-125b overexpression inhibited PTC cell proliferation, while GLUT1 overexpression promoted it.
- GLUT1 partially reversed the effects of miR-125b on glucose uptake and proliferation.
Conclusions:
- miR-125b acts as a tumor suppressor in PTC.
- miR-125b decreases glucose uptake in PTC cells primarily by downregulating GLUT1.
- The miR-125b/GLUT1 axis represents a potential therapeutic target for PTC.
Related Concept Videos
MicroRNAs
MicroRNAs

